Subscribe to Newsletter

Manufacture


Manufacture Advanced Medicine

Meet the California Institute Pushing Stem Cell & Gene Therapy Research: Part 3

| Stephanie Vine | 6 min read

Welcome back to our interview series with Jon Thomas, President and CEO of the California Institute for Regenerative Medicine: CIRM.

Manufacture Technology and Equipment

Innovation Awards: Voting Closes January 28

Who will be the grand winner of our 2024 Innovation Awards?

Manufacture Advanced Medicine

Fear Replaced by Understanding, Optimism, and Miracles: Part II

| Daniel Eisenman | 7 min read

Accelerating the progress of cell and gene therapies with decentralized trials and other innovative approaches.

Manufacture Contract Manufacturing Services

Trends and Technologies in Oral Solid Dosage Formulation

| 3 min read

The trends and challenges in oral solid dosage formulations contribute to greater stability for drugs used by patients worldwide.

Manufacture Bioprocessing - Upstream & Downstream

Mastering Oligonucleotide Manufacturing

A selection of experts from Asahi Kasei Bioprocess discuss the key practices behind successful processes.

Manufacture Advanced Medicine

Meet the California Institute Pushing Stem Cell and Gene Therapy Research: Part 2

| Stephanie Vine | 7 min read

Jon Thomas, CEO of CIRM, discusses the evolution of stem cell research and the future of regenerative medicine in this interview.

Manufacture Bioprocessing - Upstream & Downstream

The Role of Chromatography in Bioprocessing Optimization

| Ian Harwood, Laura Kronbetter | 5 min read

Understanding how choices in chromatography solutions impact overall process efficiency.

Manufacture Advanced Medicine

Advancing CRISPR: Caszyme Collaborates with Integra Therapeutics

| 4 min read

We find out why Cas12l incorporated into a gene-writing system could help advance the field of gene editing.

Manufacture Bioprocessing - Upstream & Downstream

Accelerating Cell Line Development

| Brett Verstak | 5 min read

The essential roles of optimized cell lines and vectors in accelerating bioprocessing.

Manufacture Advanced Medicine

Meet the California Institute Pushing Stem Cell and Gene Therapy Research: Part 1

| Stephanie Vine | 6 min read

Consider CIRM as a bank. We don’t conduct research ourselves: we fund it – and have become the largest dedicated funder of stem cell and gene therapy


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register